Product Information
- Firsocostat
ND-630 is a drug that has been designed to treat metabolic disorders by targeting the transcription-polymerase chain reaction of the epidermal growth factor. It has been shown to alleviate liver lesions and hepatic steatosis in mice. ND-630 may also be a potential biomarker for hepatocyte injury, as it has been shown to have an effect on energy metabolism and lipid synthesis. There is also some evidence that ND-630 may be used as an anthelmintic drug.
Chemical properties
Technical inquiry about: 3D-BN166808 ND-630
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.